This project focuses on the development of zinc doped ferrite nanoparticle based MRI contrast agents with enhanced contrast and site-specific targeting for atherosclerosis diagnosis. The engineered nanocomplexes developed were validated through MRI scans using rat models with potential for multimodal imaging and effective therapy.
Field of Research
100703 Nanobiotechnology 100709 Nanomedicine
Socio Economic Objective
920102 Cancer and Related Disorders
Description of original
xi, 475 pages : illustrations, tables, graphs, some coloured
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact email@example.com.